Latest news

Bladder Cancer Surgery Just Became a System Test
The FDA has expanded perioperative pembrolizumab plus enfortumab vedotin to all cystectomy-eligible adults with muscle-invasive bladder cancer. The approval is clinical progress. The implementation burden now moves to hospitals.

Lenacapavir Turns HIV Prevention Into an Access Stress Test

WHO’s AMR Plan Turns Access Into Preparedness

Diabetic Eye Screening Is Becoming Risk-Based

Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map

AI Eye Screening Has an Image Quality Problem

AI Retinal Screening Moves Into the Diabetes Clinic

India Turns AI Eye Screening Into Public-Health Infrastructure

Geographic Atrophy Forces Europe to Define Meaningful Vision Benefit

Eye Health Moves From Charity Case to Investment Case
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
